PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients
hyperlipidemiaretinal artery occlusionretinal vascular occlusionretinal vein occlusionthuốc ức chế PCSK9
Highlight
This retrospective cohort study demonstrated that treatment with PCSK9 inhibitors in hyperlipidemic patients significantly lowers the risk of retinal vascular occlusions, including both retinal artery and vein occlusions, over 3-, 5-, and 7-year periods compared to other lipid-lowering agents. The most pronounced risk reductions were observed for retinal vein occlusions (RVO) and central retinal vein occlusions (central RVO), suggesting robust vascular protective effects.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.